14.72
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.87%
83.34
|
84.07 | 81.80 | 73.46 | 76.21 |
| Cost Of Revenue |
4.52%
50.75
|
48.56 | 47.37 | 45.12 | 44.37 |
| Gross Profit |
8.25%
32.58
|
35.51 | 34.44 | 28.35 | 31.85 |
|
|
35.31%
68.82
|
50.86 | 54.15 | 48.14 | 47.98 |
| Benefits Costs and Expenses |
22.97%
112.61
|
91.58 | 103.32 | 85.19 | 84.26 |
| Costs And Expenses |
22.97%
112.61
|
91.58 | 103.32 | 85.19 | 84.26 |
| Operating Income/Loss |
136.08%
-36.24
|
-15.35 | -19.71 | -19.80 | -16.14 |
| Nonoperating Income/Loss |
11.18%
6.964
|
7.841 | -1.806 | 8.072 | 8.09 |
| Income/Loss From Continuing Operations Before Tax |
289.85%
-29.27
|
-7.509 | -21.52 | -11.72 | -8.045 |
| Income Tax Expense/Benefit, Deferred |
87.96%
-0.104
|
-0.864 | -0.113 | -0.133 | -0.364 |
| Income Tax Expense/Benefit |
723.43%
-5.624
|
-0.683 | -2.263 | 0.176 | -1.855 |
| Income/Loss From Continuing Operations After Tax |
246.47%
-23.65
|
-6.826 | -19.26 | -11.90 | -6.19 |
|
|
246.47%
-23.65
|
-6.826 | -19.26 | -11.90 | -6.19 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
6.42%
-0.232
|
-0.218 | -0.299 | -0.369 | -0.302 |
| Basic Average Shares |
99.78%
0.069
|
30.75 | 30.54 | 30.83 | 0.14 |
| Diluted Average Shares |
99.78%
0.069
|
30.75 | 30.54 | 30.83 | 0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):